An ELSI for AI: Learning from genetics to govern algorithms
By Alondra Nelson,
Science
| 09. 11. 2025
In the United States, the summer of 2025 will be remembered as artificial intelligence’s (AI’s) cruel summer—a season when the unheeded risks and dangers of AI became undeniably clear. Recent months have made visible the stakes of the unchecked use of AI: The parents of 16-year-old Adam Raine filed the first known wrongful death lawsuit against OpenAI, claiming ChatGPT contributed to their son's suicide by advising him on methods and offering to write his suicide note. A psychiatrist's investigation revealed that AI therapy chatbots encouraged troubled teens to “get rid of” parents and made sexual suggestions while falsely claiming to be licensed therapists. Reports emerged of a man hospitalized after following ChatGPT’s advice to add sodium bromide to his diet. Trevis Williams reportedly spent more than 2 days wrongfully jailed after facial recognition technology misidentified him despite obvious physical differences and geolocation data proving he was miles away from the crime scene.
Although comprehensive data on the frequency of AI failures—whether in absolute terms or relative to successful applications—is lacking, existing evidence makes clear that such incidents are not merely...
Related Articles
By Grace Won, KQED [with CGS' Katie Hasson] | 12.02.2025
In the U.S., it’s illegal to edit genes in human embryos with the intention of creating a genetically engineered baby. But according to the Wall Street Journal, Bay Area startups are focused on just that. It wouldn’t be the first...
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...
By Antonio Regalado, MIT Technology Review | 10.31.2025
A West Coast biotech entrepreneur says he’s secured $30 million to form a public-benefit company to study how to safely create genetically edited babies, marking the largest known investment into the taboo technology.
The new company, called Preventive, is...